Home › Kidney Cancer › North Carolina
Kidney Cancer clinical trials in North Carolina
8 studies for Kidney Cancer are looking for participants at sites in North Carolina.
Cities in North Carolina
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, Chapel Hill
- Research Site, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07011719Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
Recruiting
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07059884Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Charlotte
- Xencor Investigative Site, Durham
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT05433142Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
- The University of North Carolina, Chapel Hill
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT07225114Designing Visual Tools to Enhance Cancer Surgeon Decision-making
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- New Hanover Regional Medical Center, Wilmington
Recruiting
Ages 18 and older · All sexes · Updated Dec 5, 2025 · NCT06965192SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of North Carolina, Chapel Hill
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 27, 2025 · NCT03175224From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.